WO2009023544A3 - Dosage unit anion-exchange polymer pharmaceutical compositions - Google Patents

Dosage unit anion-exchange polymer pharmaceutical compositions Download PDF

Info

Publication number
WO2009023544A3
WO2009023544A3 PCT/US2008/072566 US2008072566W WO2009023544A3 WO 2009023544 A3 WO2009023544 A3 WO 2009023544A3 US 2008072566 W US2008072566 W US 2008072566W WO 2009023544 A3 WO2009023544 A3 WO 2009023544A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical compositions
dosage unit
exchange polymer
polymer pharmaceutical
unit anion
Prior art date
Application number
PCT/US2008/072566
Other languages
French (fr)
Other versions
WO2009023544A2 (en
Inventor
Paul Mansky
Yan Chen
Ashwini Gadre
R Gary Hollenbeck
Han Ting Chang
Dominique Charmot
Eric Connor
Original Assignee
Ilypsa Inc
Paul Mansky
Yan Chen
Ashwini Gadre
R Gary Hollenbeck
Han Ting Chang
Dominique Charmot
Eric Connor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ilypsa Inc, Paul Mansky, Yan Chen, Ashwini Gadre, R Gary Hollenbeck, Han Ting Chang, Dominique Charmot, Eric Connor filed Critical Ilypsa Inc
Publication of WO2009023544A2 publication Critical patent/WO2009023544A2/en
Publication of WO2009023544A3 publication Critical patent/WO2009023544A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

The present invention relates to pharmaceutical compositions including impregnated polymeric materials, particularly anion-exchange polymers. Processes for producing such compositions and impregnated polymers are also disclosed herein. Examples of uses for the compositions disclosed herein include the treatment of renal diseases and ion imbalances.
PCT/US2008/072566 2007-08-10 2008-08-08 Dosage unit anion-exchange polymer pharmaceutical compositions WO2009023544A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95508907P 2007-08-10 2007-08-10
US60/955,089 2007-08-10

Publications (2)

Publication Number Publication Date
WO2009023544A2 WO2009023544A2 (en) 2009-02-19
WO2009023544A3 true WO2009023544A3 (en) 2009-03-19

Family

ID=40225535

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/072566 WO2009023544A2 (en) 2007-08-10 2008-08-08 Dosage unit anion-exchange polymer pharmaceutical compositions

Country Status (1)

Country Link
WO (1) WO2009023544A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102906159B (en) * 2010-02-24 2017-09-26 瑞立普萨公司 Amine polymer as bile acid sequestrant
CA2912911C (en) 2013-06-05 2023-10-03 Tricida, Inc. Proton-binding polymers for oral administration
JP5843986B2 (en) * 2014-03-25 2016-01-13 アステラス製薬株式会社 Granular pharmaceutical composition
EP3229816B1 (en) 2014-12-10 2020-02-05 Tricida Inc. Proton-binding polymers for oral administration
US20200054669A1 (en) 2016-05-06 2020-02-20 Tricida, Inc. Compositions for and methods of treating acid-base disorders
AU2018360867A1 (en) 2017-11-03 2020-04-30 Tricida, Inc. Compositions for and method of treating acid-base disorders
WO2023036702A1 (en) 2021-09-09 2023-03-16 It Pharmagus Limited Method for the manufacturing of a solid body as an oral dosage form of a pharmaceutical or a food supplement
WO2023205379A1 (en) * 2022-04-21 2023-10-26 First Time Us Generics Llc Tablet press compression tooling assembly for the formation of soft-chew tablets and related methods

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995005184A2 (en) * 1993-08-11 1995-02-23 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
WO1998005305A1 (en) * 1996-08-06 1998-02-12 Quadrant Holdings Cambridge Ltd. Tablet dosage form of clavulanic acid and amoxycillin comprising a trehalose excipient
US20030092782A1 (en) * 2000-03-09 2003-05-15 Takeshi Goto Crosslinked anion-exchange resin or salt thereof and phosphorus adsorbent comprising the same
WO2005041900A2 (en) * 2003-11-03 2005-05-12 Ilypsa, Inc. Polyamine polymers
US20050209423A1 (en) * 2004-03-22 2005-09-22 Symyx Therapeutics, Inc. Crosslinked amine polymers
WO2005092039A2 (en) * 2004-03-22 2005-10-06 Ilypsa, Inc. Crosslinked amine polymers
WO2006043984A2 (en) * 2004-10-13 2006-04-27 Ilypsa, Inc. Crosslinked amine polymers

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995005184A2 (en) * 1993-08-11 1995-02-23 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
WO1998005305A1 (en) * 1996-08-06 1998-02-12 Quadrant Holdings Cambridge Ltd. Tablet dosage form of clavulanic acid and amoxycillin comprising a trehalose excipient
US20030092782A1 (en) * 2000-03-09 2003-05-15 Takeshi Goto Crosslinked anion-exchange resin or salt thereof and phosphorus adsorbent comprising the same
WO2005041900A2 (en) * 2003-11-03 2005-05-12 Ilypsa, Inc. Polyamine polymers
US20070110706A1 (en) * 2003-11-03 2007-05-17 Eric Connor Treatment of hyperphosphatemia using crosslinked small molecule amine polymers
US20050209423A1 (en) * 2004-03-22 2005-09-22 Symyx Therapeutics, Inc. Crosslinked amine polymers
WO2005092039A2 (en) * 2004-03-22 2005-10-06 Ilypsa, Inc. Crosslinked amine polymers
WO2006043984A2 (en) * 2004-10-13 2006-04-27 Ilypsa, Inc. Crosslinked amine polymers

Also Published As

Publication number Publication date
WO2009023544A2 (en) 2009-02-19

Similar Documents

Publication Publication Date Title
WO2009023544A3 (en) Dosage unit anion-exchange polymer pharmaceutical compositions
GB2430367B (en) Ion binding polymers and uses thereof
WO2009141823A3 (en) Conjugates of a polymer, a bisphosphonate and an anti-angiogenesis agent and uses thereof in the treatment and monitoring of bone related diseases
WO2005092039A3 (en) Crosslinked amine polymers
WO2010041268A3 (en) Crosslinked polymers
WO2009043353A3 (en) Micromirs
WO2012024620A3 (en) Autotaxin inhibitors and uses thereof
WO2010068862A3 (en) Zwitterionic polymers with therapeutic moieties
WO2012037411A3 (en) Estrogen receptor modulators and uses thereof
WO2011156518A3 (en) Estrogen receptor modulators and uses thereof
WO2007100905A3 (en) Acryloyloxyethylphosphorylcholine containing polymer conjugates and their preparation
WO2010057984A3 (en) Photocurable polymeric dielectrics and methods of preparation and use thereof
WO2006043984A3 (en) Crosslinked amine polymers
WO2009135190A3 (en) Therapeutic calcium phosphate particles and methods of making and using same
WO2008066630A3 (en) Methods for reprogramming adult somatic cells and uses thereof
WO2010120389A8 (en) Polymeric drug delivery systems and processes for producing such systems
WO2007089436A3 (en) Medical articles containing biodegradable polymers and acid-neutralizing cationic species
WO2010067078A3 (en) 3,6-disubstituted xanthylium salts as medicaments
WO2009116037A3 (en) NOVEL siRNA COMPOUNDS FOR INHIBITING RTP801
WO2010119102A3 (en) Pharmaceutical composition containing proton pump inhibitor for treating dermatological autoimmune diseases
WO2011107967A3 (en) Improved polymer membranes, processes for production thereof and use thereof
HK1109338A1 (en) Ion binding polymers and uses thereof
WO2007029093A3 (en) Pharmaceutical dosage forms of oxcarbazepine
WO2007112968A3 (en) Anti-inflammatory polymer
WO2012108631A3 (en) Pharmaceutical compositions comprising revaprazan-containing nanoparticles and processes for the preparation thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08797447

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08797447

Country of ref document: EP

Kind code of ref document: A2